This 3rd summer school is open up to researchers from both Europe and LAC regions and the experts/speakers come from both regions to facilitate the exchange of information and strategies about ELSA issues related to research on personalised Medicine. The discussion topic will be: “Implementing Personalised Medicine (PM) Research into practice: Ethical, Legal and Societal Aspects (ELSA) perspective”.
During three days, you will learn about ELSA (ethical, legal, and social aspects) related topics to Implementation research on Personalised Medicine to apply in your work.
The Summer School will offer you a European overview of the developed strategies for the use of available and new tools on PM addressing these aspects.
24-26 November 2020. Three days format: From 14:00 to 17:30 (Central European Summer Time).
The names of the speakers and the final programme will be published soon. At the moment, a draft agenda is available.
N: 30-40 participants
The participation is free of charge and open to all eligible applicants
Priority to participants from LAC countries.
Background: Mainly bio-medical and PM researchers (also admitted Healthcare providers)
Applicant folder in English language (https://www.eulac-permed.eu/):
- Application form explaining candidate’s interest in participating in the Summer School
- Declaration of Consent to The EULAC PerMed Terms & Conditions form signed.
- Short CV with reference to the candidate’s academic qualifications.
Candidates who participate in most 2/3 of the lessons and pass the final test will receive a certificate of assistance.
Deadline for applications: 15 September 2020.
About EULAC PerMed
Research on Personalised Medicine (PerMed) is a top priority for the European Union (EU) as a strategy aimed at delivering personalised health and care solutions to benefit citizens. In order to strengthen the global efforts on Personalised Medicine and the cooperation of Europe (EU) with Latin American and Caribbean (LAC) countries , the EULAC PerMed project, funded by the Horizon 2020 Programme of the European Commission, has been launched in January 2019. A unique bi-regional consortium of governmental and funding organisations, with the support of leading stakeholders as associated partners, will be in charge of developing the project until December 2021.
EULAC PerMed has the ambition to engage LAC countries in the International Consortium on Personalised Medicine (ICPerMed) and in the ERANet ERAPerMed with the aim at advancing in the implementation of the Action Plan of ICPerMed (LINK).